BIOCRYST PHARMACEUTICALS INC — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Barnes Alane P | VP, General Counsel & Corp Sec | Tax Withholding | 2,210 | $11.17 | $24,686 | 72,370 | Jan 20, 2015 |
| Sheridan William P | Senior VP - CMO | Tax Withholding | 5,074 | $11.17 | $56,677 | 95,609 | Jan 20, 2015 |
| Babu Yarlagadda S | Senior VP - Drug Discovery | Tax Withholding | 4,362 | $11.17 | $48,724 | 210,331 | Jan 20, 2015 |
| Cohen Fred E | — | Option Exercise | 100,000 | $1.29 | $129,000 | 101,457 | Jan 8, 2015 |
| Babu Yarlagadda S | Senior VP - Drug Discovery | Tax Withholding | 2,402 | $12.16 | $29,208 | 214,693 | Jan 1, 2015 |
| Stonehouse Jon P | President & CEO | Tax Withholding | 5,652 | $12.16 | $68,728 | 664,888 | Jan 1, 2015 |
| STAAB THOMAS R II | Senior Vice President and CFO | Award / Grant | 8,900 | — | — | 171,842 | Jan 1, 2015 |
| Sheridan William P | Senior VP - CMO | Tax Withholding | 2,735 | $12.16 | $33,258 | 100,683 | Jan 1, 2015 |
| Barnes Alane P | VP, General Counsel & Corp Sec | Award / Grant | 4,800 | — | — | 77,033 | Jan 1, 2015 |
| Sheridan William P | Senior VP - CMO | Option Exercise | 17,000 | $5.45 | $92,650 | 183,417 | Dec 29, 2014 |
| STAAB THOMAS R II | Senior Vice President and CFO | Option Exercise | 9,500 | $3.78 | $35,910 | 172,442 | Dec 29, 2014 |
| Cohen Fred E | — | Award / Grant | 809 | $10.81 | $8,745 | 1,457 | Nov 28, 2014 |
| Cohen Fred E | — | Award / Grant | 648 | $13.50 | $8,748 | 648 | Aug 29, 2014 |
| STAAB THOMAS R II | Senior Vice President and CFO | Sale | 10,000 | $13.58 | $135,800 | 162,942 | Aug 27, 2014 |
| STAAB THOMAS R II | Senior Vice President and CFO | Option Exercise | 26,455 | $3.78 | $100,000 | 170,756 | Jul 25, 2014 |
| STAAB THOMAS R II | Senior Vice President and CFO | Option Exercise | 3,125 | $4.73 | $14,781 | 147,426 | Jul 1, 2014 |
| STAAB THOMAS R II | Senior Vice President and CFO | Sale | 3,125 | $12.49 | $39,031 | 144,301 | Jun 23, 2014 |
| STAAB THOMAS R II | Senior Vice President and CFO | Option Exercise | 3,125 | $4.73 | $14,781 | 147,426 | Jun 17, 2014 |
| Sheridan William P | Senior VP - CMO | Tax Withholding | 1,644 | $9.86 | $16,210 | 148,173 | Jun 3, 2014 |
| STAAB THOMAS R II | Senior Vice President and CFO | Option Exercise | 17,685 | $3.78 | $66,849 | 144,301 | May 22, 2014 |
| Stonehouse Jon P | President & CEO | Option Exercise | 3,801 | $3.26 | $12,391 | 634,043 | May 9, 2014 |
| ABERCROMBIE GEORGE B | — | Option Exercise | 4,000 | $1.71 | $6,840 | 10,000 | Mar 31, 2014 |
| STAAB THOMAS R II | Senior Vice President and CFO | Sale | 3,125 | $11.24 | $35,125 | 126,616 | Mar 14, 2014 |
| LEE KENNETH B JR | — | Option Exercise | 22,917 | $3.80 | $87,085 | 22,917 | Mar 6, 2014 |
| Babu Yarlagadda S | Senior VP - Drug Discovery | Option Exercise | 23,679 | $8.83 | $209,086 | 248,837 | Mar 4, 2014 |
| Barnes Alane P | VP, General Counsel & Corp Sec | Option Exercise | 6,156 | $6.68 | $41,122 | 99,838 | Mar 4, 2014 |
| STAAB THOMAS R II | Senior Vice President and CFO | Sale | 3,000 | $12.69 | $38,070 | 126,616 | Mar 1, 2014 |
| Sheridan William P | Senior VP - CMO | Tax Withholding | 1,739 | $11.69 | $20,329 | 137,122 | Mar 1, 2014 |
| Stonehouse Jon P | President & CEO | Tax Withholding | 5,118 | $11.69 | $59,829 | 630,242 | Mar 1, 2014 |
| Babu Yarlagadda S | Senior VP - Drug Discovery | Option Exercise | 23,179 | $4.30 | $99,670 | 229,809 | Feb 24, 2014 |
| Babu Yarlagadda S | Senior VP - Drug Discovery | Award / Grant | 54,000 | — | — | 206,630 | Jan 20, 2014 |
| Stonehouse Jon P | President & CEO | Award / Grant | 128,000 | — | — | 632,360 | Jan 20, 2014 |
| STAAB THOMAS R II | Senior Vice President and CFO | Award / Grant | 54,000 | — | — | 126,218 | Jan 20, 2014 |
| Sheridan William P | SR VP - CMO | Award / Grant | 54,000 | — | — | 136,539 | Jan 20, 2014 |
| Barnes Alane P | VP, General Counsel & Corp Sec | Award / Grant | 27,000 | — | — | 81,487 | Jan 20, 2014 |
| Barnes Alane P | VP, General Counsel & Corp Sec | Option Exercise | 13,500 | $1.20 | $16,200 | 55,978 | Jan 14, 2014 |
| STAAB THOMAS R II | Senior Vice President and CFO | Tax Withholding | 12,621 | $10.55 | $133,152 | 72,218 | Jan 13, 2014 |
| Barnes Alane P | VP, General Counsel & Corp Sec | Tax Withholding | 2,453 | $7.60 | $18,643 | 42,478 | Jan 1, 2014 |
| Babu Yarlagadda S | VP Drug Discovery | Tax Withholding | 2,402 | $7.60 | $18,255 | 152,630 | Jan 1, 2014 |
| Stonehouse Jon P | President & CEO | Tax Withholding | 8,592 | $7.60 | $65,299 | 504,360 | Jan 1, 2014 |
| STAAB THOMAS R II | Senior Vice President and CFO | Tax Withholding | 2,453 | $7.60 | $18,643 | 49,614 | Jan 1, 2014 |
| Sheridan William P | SR VP - CMO | Tax Withholding | 2,735 | $7.60 | $20,786 | 82,539 | Jan 1, 2014 |
| ABERCROMBIE GEORGE B | — | Purchase | 3,000 | $6.19 | $18,570 | 6,000 | Nov 12, 2013 |
| 14159, L.P. | — | Purchase | 24,705 | $4.40 | $108,702 | 145,533 | Aug 1, 2013 |
| Sheridan William P | SR VP - CMO | Option Exercise | 16,407 | $1.20 | $19,688 | 82,274 | May 28, 2013 |
| Stonehouse Jon P | President & CEO | Option Exercise | 179,600 | $1.20 | $215,520 | 509,952 | May 23, 2013 |
| ABERCROMBIE GEORGE B | — | Purchase | 3,000 | $1.23 | $3,690 | 3,000 | Mar 5, 2013 |
| STAAB THOMAS R II | Senior Vice President and CFO | Tax Withholding | 542 | $1.19 | $645 | 49,322 | Mar 1, 2013 |
| Sheridan William P | SR VP - CMO | Tax Withholding | 1,789 | $1.19 | $2,129 | 62,867 | Mar 1, 2013 |
| Babu Yarlagadda S | VP Drug Discovery | Tax Withholding | 1,903 | $1.19 | $2,265 | 155,032 | Mar 1, 2013 |